spacer
spacer

PDBsum entry 1ksw

Go to PDB code: 
protein ligands links
Transferase PDB id
1ksw

 

 

 

 

Loading ...

 
JSmol PyMol  
Contents
Protein chain
450 a.a. *
Ligands
NBS
Waters ×46
* Residue conservation analysis
PDB id:
1ksw
Name: Transferase
Title: Structure of human c-src tyrosine kinase (thr338gly mutant) in complex with n6-benzyl adp
Structure: Proto-oncogene tyrosine-protein kinase src. Chain: a. Fragment: sh3, sh2 and kinase domains. Synonym: c-src. Engineered: yes. Mutation: yes
Source: Homo sapiens. Human. Organism_taxid: 9606. Expressed in: spodoptera frugiperda. Expression_system_taxid: 7108. Expression_system_cell_line: sf9.
Resolution:
2.80Å     R-factor:   0.231     R-free:   0.294
Authors: L.A.Witucki,X.Huang,K.Shah,Y.Liu,S.Kyin,M.J.Eck,K.M.Shokat
Key ref:
L.A.Witucki et al. (2002). Mutant tyrosine kinases with unnatural nucleotide specificity retain the structure and phospho-acceptor specificity of the wild-type enzyme. Chem Biol, 9, 25-33. PubMed id: 11841936 DOI: 10.1016/S1074-5521(02)00091-1
Date:
14-Jan-02     Release date:   27-Feb-02    
PROCHECK
Go to PROCHECK summary
 Headers
 References

Protein chain
Pfam   ArchSchema ?
P12931  (SRC_HUMAN) -  Proto-oncogene tyrosine-protein kinase Src from Homo sapiens
Seq:
Struc:
 
Seq:
Struc:
536 a.a.
450 a.a.*
Key:    PfamA domain  Secondary structure  CATH domain
* PDB and UniProt seqs differ at 1 residue position (black cross)

 Enzyme reactions 
   Enzyme class: E.C.2.7.10.2  - non-specific protein-tyrosine kinase.
[IntEnz]   [ExPASy]   [KEGG]   [BRENDA]
      Reaction: L-tyrosyl-[protein] + ATP = O-phospho-L-tyrosyl-[protein] + ADP + H+
L-tyrosyl-[protein]
+ ATP
= O-phospho-L-tyrosyl-[protein]
Bound ligand (Het Group name = NBS)
matches with 79.41% similarity
+ ADP
+ H(+)
Molecule diagrams generated from .mol files obtained from the KEGG ftp site

 

 
    Added reference    
 
 
DOI no: 10.1016/S1074-5521(02)00091-1 Chem Biol 9:25-33 (2002)
PubMed id: 11841936  
 
 
Mutant tyrosine kinases with unnatural nucleotide specificity retain the structure and phospho-acceptor specificity of the wild-type enzyme.
L.A.Witucki, X.Huang, K.Shah, Y.Liu, S.Kyin, M.J.Eck, K.M.Shokat.
 
  ABSTRACT  
 
The direct substrates of one protein kinase in a cell can be identified by mutation of the ATP binding pocket to allow an unnatural ATP analog to be accepted exclusively by the engineered kinase. Here, we present structural and functional assessment of peptide specificity of mutant protein kinases with unnatural ATP analogs. The crystal structure (2.8 A resolution) of c-Src (T338G) with N(6)-(benzyl) ADP bound shows that the creation of a unique nucleotide binding pocket does not alter the phospho-acceptor binding site of the kinase. A panel of optimal peptide substrates of defined sequence, as well as a degenerate peptide library, was utilized to assess the phospho-acceptor specificity of the engineered "traceable" kinases. The specificity profiles for the mutant kinases were found to be identical to those of their wild-type counterparts.
 
  Selected figure(s)  
 
Figure 1.
Figure 1. Chemical Structures of A*TP Analogs Used in This Study1: N^6-(benzyl) ATP; 2: N^6-(cyclopentyl) ATP. Definitions of analog-sensitive (as) kinase mutants used in this study.
Figure 2.
Figure 2. Comparison of Wild-Type and Analog-Specific c-Src Crystal Structures(A) The crystal structure of c-Src-as1 superimposed on wild-type c-Src. c-Src-as1 is shown in gray, and c-Src is in red. The rmsd for the overlay is 0.35 Å.(B) The binding of the A*TP analog, N^6-(benzyl) ADP to the mutant c-Src (T338G) kinase. The surface corresponding to the glycine residue at the 338 position is colored red. The benzyl ring of the A*TP analog projects into a pocket in the nucleotide binding cleft. This pocket is made accessible by the c-Src (T338G) point mutation. For clarity, the 11 residues that bind over the nucleotide at the front of the nucleotide cleft are omitted from the figure in order to more clearly show the surface at the back of the nucleotide binding pocket where the 338 residue lies. The omitted residues are c-Src 272–282.(C) The steric clash of the wild-type c-Src threonine residue at the 338 position, shown in red, with the N^6-(benzyl) ATP analog (blue). The gray surface was built over the crystal structure of the mutant kinase overlayed with the wild-type c-Src crystal structure, and the surface was rendered over threonine 338 (red). The N^6-(benzyl) ADP (blue) is superimposed on the AMP-PNP ligand (yellow).
 
  The above figures are reprinted by permission from Cell Press: Chem Biol (2002, 9, 25-33) copyright 2002.  
  Figures were selected by an automated process.  

Literature references that cite this PDB file's key reference

  PubMed id Reference
21037565 T.Su, D.M.Bryant, F.Luton, M.Vergés, S.M.Ulrich, K.C.Hansen, A.Datta, D.J.Eastburn, A.L.Burlingame, K.M.Shokat, and K.E.Mostov (2010).
A kinase cascade leading to Rab11-FIP5 controls transcytosis of the polymeric immunoglobulin receptor.
  Nat Cell Biol, 12, 1143-1153.  
19437469 L.M.Elphick, S.E.Lee, E.S.Child, A.Prasad, C.Pignocchi, S.Thibaudeau, A.A.Anderson, L.Bonnac, V.Gouverneur, and D.J.Mann (2009).
A quantitative comparison of wild-type and gatekeeper mutant cdk2 for chemical genetic studies with ATP analogues.
  Chembiochem, 10, 1519-1526.  
19406749 T.P.Abeyweera, X.Chen, and S.A.Rotenberg (2009).
Phosphorylation of alpha6-tubulin by protein kinase Calpha activates motility of human breast cells.
  J Biol Chem, 284, 17648-17656.  
18282484 B.E.Turk (2008).
Understanding and exploiting substrate recognition by protein kinases.
  Curr Opin Chem Biol, 12, 4.  
18451558 Y.Mori, T.Hirokawa, K.Aoki, H.Satomi, S.Takeda, M.Aburada, and K.Miyamoto (2008).
Structure activity relationships of quinoxalin-2-one derivatives as platelet-derived growth factor-beta receptor (PDGFbeta R) inhibitors, derived from molecular modeling.
  Chem Pharm Bull (Tokyo), 56, 682-687.  
17334377 J.A.Blair, D.Rauh, C.Kung, C.H.Yun, Q.W.Fan, H.Rode, C.Zhang, M.J.Eck, W.A.Weiss, and K.M.Shokat (2007).
Structure-guided development of affinity probes for tyrosine kinases using chemical genetics.
  Nat Chem Biol, 3, 229-238.
PDB codes: 2hwo 2hwp 2j5e 2j5f
17486086 J.J.Allen, M.Li, C.S.Brinkworth, J.L.Paulson, D.Wang, A.Hübner, W.H.Chou, R.J.Davis, A.L.Burlingame, R.O.Messing, C.D.Katayama, S.M.Hedrick, and K.M.Shokat (2007).
A semisynthetic epitope for kinase substrates.
  Nat Methods, 4, 511-516.  
16135530 K.Shah, and F.Vincent (2005).
Divergent roles of c-Src in controlling platelet-derived growth factor-dependent signaling in fibroblasts.
  Mol Biol Cell, 16, 5418-5432.  
15357923 J.A.Whitney (2004).
Reference systems for kinase drug discovery: chemical genetic approaches to cell-based assays.
  Assay Drug Dev Technol, 2, 417-429.  
14595109 L.Wan, T.de los Santos, C.Zhang, K.Shokat, and N.M.Hollingsworth (2004).
Mek1 kinase activity functions downstream of RED1 in the regulation of meiotic double strand break repair in budding yeast.
  Mol Biol Cell, 15, 11-23.  
14749387 Y.Liu, C.Kung, J.Fishburn, A.Z.Ansari, K.M.Shokat, and S.Hahn (2004).
Two cyclin-dependent kinases promote RNA polymerase II transcription and formation of the scaffold complex.
  Mol Cell Biol, 24, 1721-1735.  
14574415 J.A.Ubersax, E.L.Woodbury, P.N.Quang, M.Paraz, J.D.Blethrow, K.Shah, K.M.Shokat, and D.O.Morgan (2003).
Targets of the cyclin-dependent kinase Cdk1.
  Nature, 425, 859-864.  
14700620 P.M.Fischer (2003).
CDK versus GSK-3 inhibition: a purple haze no longer?
  Chem Biol, 10, 1144-1146.  
12546954 K.Shokat, and M.Velleca (2002).
Novel chemical genetic approaches to the discovery of signal transduction inhibitors.
  Drug Discov Today, 7, 872-879.  
The most recent references are shown first. Citation data come partly from CiteXplore and partly from an automated harvesting procedure. Note that this is likely to be only a partial list as not all journals are covered by either method. However, we are continually building up the citation data so more and more references will be included with time. Where a reference describes a PDB structure, the PDB codes are shown on the right.

 

spacer

spacer